Protalix BioTherapeutics (PLX)

• Market cap: $172M
• 1 day: 1.9%
• 5 days: 12.04%
• 1 month: -0.93%
• 3 months: -28.9%
• 6 months: 16.94%
• Year to date: 22.99%
• 1 year: 37.18%
• 5 years: -27.21%
• 10 years: -72.67%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Employees: 226